CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, Ravindra, Chao, Mark P., Alizadeh, Ash A., Pang, Wendy W., Jaiswal, Siddhartha, Gibbs, Kenneth D., van Rooijen, Nico, Weissman, Irving L.·2009·Cell

DOI 10.1016/j.cell.2009.05.045

Cited by (1,001)

Items 801–900 of 1,001

CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling
Xia Fang, Chi-Qi Chen, Fangzhen Xia, Zhuo Yu, Yaping Zhang, Feifei Zhang, Hao Gu, Jiang-Bo Wan, Xiao-Cui Zhang, W. Weng et al. · 2016 · Journal of Hematology & Oncology
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients
Mario Tiribelli, Donatella Raspadori, Antonella Geromin, Margherita Cavallin, Santina Sirianni, Erica Simeone, Monica Bocchia, Renato Fanin, Daniela Damiani · 2017 · Leukemia Research
High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma
Wenhua Fu, Jisen Li, Wei Zhang, Peng Li · 2017 · Biomedicine & Pharmacotherapy
Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial–Mesenchymal Transition Score in Prognosis Prediction
Ying-Chieh Ko, Ting-Yu Lai, Shu-Ching Hsu, Fu-Hui Wang, Sheng-Yao Su, Yu-Lian Chen, Min-Lung Tsai, Chung-Chun Wu, Jenn‐Ren Hsiao, Jang‐Yang Chang et al. · 2020 · Cancers
SIRPα: A key player in innate immunity
Yongyi Feng, Chunliu Huang, Yingzhao Wang, Jun Chen · 2023 · European Journal of Immunology
Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
Yu Liu, Jianhui Ma, Yiming Ma, B.-C. Wang, Yinong Wang, Junhu Yuan, Fanyu Zhang, Xinhua Zhao, Kun Chen, Xiaoli Zhang et al. · 2025 · Journal for ImmunoTherapy of Cancer
Integration of active ingredients from traditional Chinese medicine with nano-delivery systems for tumor immunotherapy
Hao Zheng, Yiquan Chen, Wei Luo, Shiqi Han, Mengjuan Sun, Lin Min, Cheng-Han Wu, Lili Gao, Tian Xie, Na Kong · 2025 · Journal of Nanobiotechnology
Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors
Cariad Chester, Aurélien Marabelle, Roch Houot, Holbrook E K Kohrt · 2015 · Current Opinion in Immunology
AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells
Dongmei Fan, Zhenzhen Li, Xiaolong Zhang, Yuqi Yang, Xiangfei Yuan, Xiuli Zhang, Ming Yang, Yizhi Zhang, Dongsheng Xiong · 2015 · Journal of Hematology & Oncology
New Advances and Challenges of Targeting Cancer Stem Cells
Nurmaa Khund Dashzeveg, Rokana Taftaf, Erika K. Ramos, Luke A. Torre-Healy, Anastasia P. Chumakova, Daniel J. Silver, Tyler Joseph Alban, Maksim Sinyuk, Praveena Shree Thiagarajan, Awad Jarrar et al. · 2017 · Cancer Research
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu et al. · 2020 · Cancer Biology and Medicine
Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure
Kui Chen, Yujiao Wang, Haojun Liang, Huan Huang, Yuelan Liang, Jiaxin Zhang, Yanan Chang, Juan Li, Min Fang, Gengmei Xing · 2021 · Nano Today
A dual-catalytic nanoreactor for synergistic chemodynamic-starvation therapy toward tumor metastasis suppression
Huiwen Zhang, Fei Lü, Wei Pan, Yegang Ge, Bingjie Cui, Shaohua Gong, Na Li, Bo Tang · 2021 · Biomaterials Science
A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy
Hasaan Hayat, Hanaan Hayat, Bennett Francis Dwan, Mithil Gudi, Jack Owen Bishop, Ping Wang · 2021 · OncoTargets and Therapy
CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
Jennifer Sun, Yixuan Chen, Berit Lubben, Ola Adebayo, Barbara Muz, Abdel Kareem Azab · 2021 · Leukemia Research Reports
Advances in the study of CD47 ‐based bispecific antibody in cancer immunotherapy
Binglei Zhang, Wei Li, Dandan Fan, Wenzhi Tian, Jian Zhou, Zhenyu Ji, Yongping Song · 2022 · Immunology
Peptide nano ‘bead-grafting’ for SDT-facilitated immune checkpoints blocking
Limin Zhang, Yuwei Tian, Mengzhen Li, Minxuan Wang, Shang Wu, Zhenqi Jiang, Qiqin Wang, Weizhi Wang · 2022 · Chemical Science
N-Cadherin and Tie2 positive CD34+CD38−CD123+ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID mice
Shaowei Qiu, Yujiao Jia, Haiyan Xing, Tengteng Yu, Jing Yu, Pei Yu, Kejing Tang, Zheng Tian, Huijun Wang, Yingchang Mi et al. · 2014 · Leukemia Research
Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine
Mao Lin, Yuan-Ying Yuan, Shu-Peng Liu, Juan-Juan Shi, Xin-An Long, Li-Zhi Niu, Ji-Bing Chen, Qiao Li, Ke-Cheng Xu · 2015 · Journal of Cancer Research and Clinical Oncology
Structural–functional diversity of CD47 proteoforms
Ting Zhang, Feng Wang, Lu Xu, Yong‐Guang Yang · 2024 · Frontiers in Immunology
Intracellular Magnetic Hyperthermia Enables Concurrent Down-Regulation of CD47 and SIRPα To Potentiate Antitumor Immunity
Siyao Wang, Wangbo Jiao, Bin Yan, Xiaofei Liu, Qianqian Tang, Yihan Zhang, Chen Liang, Xun Wang, Yi Lyu, Haiming Fan et al. · 2024 · Nano Letters
Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis
Chen Zhang, Yi Liu, Jiayu Jiang, Chong Chen, Zhaojun Duan, Huifang Su, Shijian Wang, Baorui Tian, Yi Shi, Rong Xiang et al. · 2024 · Theranostics
HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing
Hong Wu, Yiqiang Liu, Qianshi Liu, Zhaoshen Li, Yejian Wan, Chenhui Cao, Binghuo Wu, Mingxin Liu, Renchuan Liang, Lanlin Hu et al. · 2024 · Science Advances
Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC ‐209 in acute myeloid leukemia: Implications for leukemia therapy
Yuki Nishida, Aya Maeda, Dhruv Chachad, Jo Ishizawa, Yi Hua Qiu, Steven Mitchell Kornblau, Shinya H Kimura, Michael Andreeff, Kensuke Kojima · 2015 · Cancer Science
A fully human anti-CD47 blocking antibody with therapeutic potential for cancer
Dadi Zeng, Qiang Sun, Ang Chen, Jiangfeng Fan, Xiaopeng Yang, Lei Xu, Peng Du, Weiyi Qiu, Weicai Zhang, Shuang Wang et al. · 2016 · Oncotarget
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes
Di Cao, Meng‐Ke Chen, Qing-Feng Zhang, Yu-Feng Zhou, Mei‐Yin Zhang, Shi‐Juan Mai, Yaojun Zhang, Minshan Chen, Xiaoxing Li, Hui‐Yun Wang · 2020 · Aging
Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy
Susan Moradinasab, Atieh Pourbagheri‐Sigaroodi, Seyed Hamidollah Ghaffari, Davood Bashash · 2021 · International Immunopharmacology
Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma
Miaomiao Li, Hui Yu, Fei Qi, Yingying Ye, Dingyao Hu, Jiaowu Cao, Dedao Wang, Lan Mi, Zhengyi Wang, Ning Ding et al. · 2022 · Hematological Oncology
Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer
Antonieta Chávez‐González, Babak Bakhshinejad, Katayoon Pakravan, Mónica L. Guzmán, Sadegh Babashah · 2016 · Cellular Oncology
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
Elie Dheilly, Stefano Majocchi, Valéry Moine, Gérard Didelot, Lucile Broyer, Sébastien Calloud, Pauline Malinge, Laurence Chatel, Walter G. Ferlin, Marie H. Kosco‐Vilbois et al. · 2018 · Antibodies
Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges
Mansour Alfayez, Gautam M. Borthakur · 2018 · Expert Review of Hematology
The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia
Jianfeng Guo, Xue Luan, Zhongcheng Cong, Yao Sun, Limei Wang, Sharon L. McKenna, Mary R. Cahill, Caitríona M. O’Driscoll · 2018 · Journal of Controlled Release
A human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells
Fumiaki Jinnouchi, Takuji Yamauchi, Ayano Yurino, Takuya Nunomura, Michitaka Nakano, Chika Iwamoto, Teppei Obara, Kohta Miyawaki, Yoshikane Kikushige, Koji Kato et al. · 2020 · Blood
Spontaneous Cell Fusion of Acute Leukemia Cells and Macrophages Observed in Cells with Leukemic Potential
Inés Martín-Padura, Paola Marighetti, Giuliana Gregato, Alice Agliano, Omar Malazzi, Patrizia Mancuso, Giancarlo Pruneri, Andrea Viale, Francesco Bertolini · 2012 · Neoplasia
Inflammation and Cancer
Sushil Kumar, Christopher J. Chan, Lisa M. Coussens · 2016 · Elsevier eBooks
CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer
Jiaqi Liang, Guoshu Bi, Xiaolong Huang, Zhijie Xu, Yiwei Huang, Yunyi Bian, Guangyao Shan, Wei Guo, Yuanliang Yan, Qihai Sui et al. · 2025 · 癌症：英文版
The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
H. Karlic, H. Herrmann, F. Varga, R. Thaler, R. Reitermaier, S. Spitzer, V. Ghanim, K. Blatt, W. Sperr, P. Valent et al. · 2014 · Critical reviews in oncology/hematology
Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance
Theodoros Karantanos, Richard John Jones · 2019 · Advances in experimental medicine and biology
Immunogenic Cell Death Driven by Radiation—Impact on the Tumor Microenvironment
Takahiro Yamazaki, Claire Vanpouille‐Box, Sandra Demaria, Lorenzo Galluzzi · 2020 · Cancer treatment and research
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis
Oliver Kepp, Peng Liu, Liwei Zhao, Isabelle Plo, Guido Kroemer · 2020 · OncoImmunology
The promise of macrophage directed checkpoint inhibitors in myeloid malignancies
David M. Swoboda, David Andrew Sallman · 2020 · Best Practice & Research Clinical Haematology
An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
Xinmin Wang, Ying Wang, Jialiang Hu, Hanmei Xu · 2021 · Cancer Medicine
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
Anna Aureli, Beatrice Marziani, Tommaso Sconocchia, Maria Ilaria Del Principe, Elisa Buzzatti, Gianmario Pasqualone, Adriano Venditti, Giuseppe Sconocchia · 2021 · Cancers
Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers
Deyang Wu, Xiaowei Liu, Jingtian Mu, Jin Yang, Fanglong Wu, Hongmei Zhou · 2022 · Biomolecules
The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes
Sara Hadjigol, Bansari A. Shah, Neil Martin O’brien-simpson · 2022 · Frontiers in Immunology
Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases
Yidan Zhang, Yifan Wang, Zhan Zhao, Weixun Peng, Peng Wang, Ximing Xu, Chenyang Zhao · 2022 · European Journal of Pharmacology
New Immuno-oncology Targets and Resistance Mechanisms
Molly C. Tokaz, Christina S. Baik, A. McGarry Houghton, Diane Tseng · 2022 · Current Treatment Options in Oncology
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations
Guillermo Garcia‐Manero · 2022 · The Lancet Haematology
Novel immunotherapies in the treatment of AML: is there hope?
Marion S. Subklewe, Veit Bücklein, David Andrew Sallman, Naval Guastad Daver · 2023 · Hematology
Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform
Yuemin Wang, Hong Xu, Duan Wang, Yongping Lu, Yuyue Zhang, Jing Cheng, Xinyuan Xu, Xingyu Chen, Jianshu Li · 2023 · Acta Biomaterialia
Recent advancements of hydrogels in immunotherapy: Breast cancer treatment
Jagannath Mondal, Kushal Chakraborty, Edwin J. Bunggulawa, Jeong Man An, Vishnu Revuri, Md Nurunnabi, Yong-Kyu Lee · 2024 · Journal of Controlled Release
The road to purified hematopoietic stem cell transplants is paved with antibodies
Aaron C. Logan, Irving L. Weissman, Judith A. Shizuru · 2012 · Current Opinion in Immunology
Activation of phagocytosis by immune checkpoint blockade
Chia‐Wei Li, Yun‐Ju Lai, Jennifer L. Hsu, Mien‐Chie Hung · 2018 · Frontiers of Medicine
Immune checkpoint blockade in hematological malignancies: current state and future potential
Prateek A. Pophali, Juan Carlos Varela, Jacalyn M. Rosenblatt · 2024 · Frontiers in Oncology
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma
Joseph E. Maakaron, Adam Steven Asch, Leslie L. Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colm Keane, Matthew Ku, Amitkumar Mehta, Mark J. Roschewski et al. · 2024 · Blood Advances
Defective neutrophil clearance in JAK2 V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24
Eman Khatib-Massalha, Christian Andrea Di Buduo, Agathe L. Chédeville, Ya‐Hsuan Ho, Yexuan Zhu, Élodie Grockowiak, Yuki Date, Lam T. Khuat, Zijian Fang, Jose Quesada-Salas et al. · 2025 · Blood
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance
Cheng Zhong, Lixiang Wang, Yujia Liu, Xinyu Wang, Zijin Xia, Yiyi Li, Yao Zhang, Jing Liao, Xianmiao Wang, Chen-Yang Liao et al. · 2025 · Science Immunology
CD123 as a Therapeutic Target Against Malignant Stem Cells
Mayumi Sugita, Mónica L. Guzmán · 2020 · Hematology/Oncology Clinics of North America
Review Cancer stem cells in haematological malignancies
Radosław Zagożdżon, Jakub Gołąb · 2015 · Współczesna Onkologia
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes
Shai O. Shimony, Richard Maury Stone, Maximilian F. Stahl · 2021 · Current Opinion in Hematology
Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act
Xujun Cao, Anthony F. Cordova, Lingyin Li · 2021 · Chemical Reviews
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
Xavier Chauchet, Laura Cons, Laurence Chatel, Bruno Daubeuf, Gérard Didelot, Valéry Moine, Didier Chollet, Pauline Malinge, Guillemette Pontini, Krzysztof Masternak et al. · 2022 · Experimental Hematology and Oncology
A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome
Héléna Boutzen, Seyed Ali Madani Tonekaboni, Michelle Chan‐Seng‐Yue, Alex Murison, Naoya Takayama, Nathan Mbong, Elvin Wagenblast, Elias Orouji, Andrea Arruda, Amanda Mitchell et al. · 2022 · Leukemia
Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
Linheng Li, Roy A. Jensen · 2023 · Cancer Research
Update on immune‐based therapy strategies targeting cancer stem cells
Amirhossein Izadpanah, Niloufar Mohammadkhani, Mina Masoudnia, Mahsa Ghasemzad, Arefeh Saeedian, Hamid Mehdizadeh, Mansour Poorebrahim, Marzieh Ebrahimi · 2023 · Cancer Medicine
Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes
Benjamin Nils Ostendorf, Eva Flenner, Anne Flörcken, Jörg Westermann · 2018 · PLoS ONE
Porcine signal regulatory protein alpha binds to human CD47 to inhibit phagocytosis: Implications for human hematopoietic stem cell transplantation into severe combined immunodeficient pigs
Adeline N. Boettcher, Joan E. Cunnick, Ellie J. Putz, Timothy K. Egner, Sara E. Charley, Crystal Lynn Loving, Christopher Keith Tuggle · 2018 · Xenotransplantation
Targeting TP53 Mutations in Myelodysplastic Syndromes
Anthony Michael Hunter, David Andrew Sallman · 2019 · Hematology/Oncology Clinics of North America
A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune
Zhenzhen Jiang, Guangqing Cai, Haiting Liu, Leping Liu, Rong Huang, Xinmin Nie, Rong Gui, Jian Li, Jinqi Ma, Ke Cao et al. · 2024 · Journal of Nanobiotechnology
Mithramycin and its analogs: Molecular features and antitumor action
José Portugal · 2024 · Pharmacology & Therapeutics
Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity
Zengpeng Li, Mengyuan Li, Yang Liu, Jie Chen, Qian Ye, Wenbin Qian, Shibing Wang · 2024 · Journal for ImmunoTherapy of Cancer
SIGLEC11 promotes M2 macrophage polarization through AKT–mTOR signaling and facilitates the progression of gastric cancer
Jingxin Yin, Lu Yang, Yihao Liu, Qimeng Shi, Minmin Shi, Zhenggang Zhu, Da Fu, Zhenqiang Wang, Chen Li · 2025 · Journal for ImmunoTherapy of Cancer
Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities
Sivapar V. Mathan, Rana Pratap Singh · 2025 · Cancers
Can immunotherapy specifically target acute myeloid leukemic stem cells?
Sylvia Snauwaert, Bart Vandekerckhove, Tessa C. C. Kerre · 2013 · OncoImmunology
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
Maria Ilaria Del Principe · 2016 · Mediterranean Journal of Hematology and Infectious Diseases
Multifunctional Immunoliposomes Enhance the Immunotherapeutic Effects of PD‐L1 Antibodies against Melanoma by Reprogramming Immunosuppressive Tumor Microenvironment
Yu Hei, Chen Yang, Qian Li, Zi Mei, Jijia Pan, Siqi Zhang, Chunyang Xiong, Xiao‐Dong Su, Shicheng Wei · 2021 · Small
Emerging Concepts of Vascular Cell Clonal Expansion in Atherosclerosis
Ashish Misra, Rajan Rehan, Alexander Lin, Sanjay Patel, Edward A. Fisher · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
Targeting tumor-associated macrophages for cancer immunotherapy
Xu Cao, Seigmund Wai Tsuen Lai, Siqi Chen, Sadira Wang, Mingye Feng · 2022 · International review of cytology
Myeloid checkpoints for cancer immunotherapy
Yixin Qian, Ting Yang, Huan Liang, Mi Deng · 2022 · Chinese Journal of Cancer Research
A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
Başak Aru, Cemil Pehlivanoğlu, Zeynep Dal, Nida Nur DERELI-CALISKAN, Ege Gürlü, Gülderen Yanıkkaya Demirel · 2023 · Frontiers in Immunology
The DNA damage response pathway regulates the expression of the immune checkpoint CD47
Lucy Ghantous, Yael Volman, Ruth Hefez, Ori Wald, Esther Stern, Tomer Friehmann, Ayelet Chajut, Edwin Bremer, Michal Dranitzki Elhalel, Jacob Rachmilewitz · 2023 · Communications Biology
Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination
Chih‐Wei Chou, Chia‐Nung Hung, Cheryl Hsiang-Ling Chiu, Xi Tan, Meizhen Chen, Chien‐Chin Chen, Moawiz Saeed, Che‐Wei Hsu, Michael Andre Liss, Chiou‐Miin Wang et al. · 2023 · Nature Communications
Treatment of Acute Myeloid Leukemia in Older Adults
Aseel Alsouqi, Emily M. Geramita, Annie Im · 2023 · Cancers
How do tumor stem cells actively escape from host immunosurveillance?
Yao Qi, Run-Mei Li, Fan-Ming Kong, Hui zi Li, Jin-Pu Yu, Xiu-Bao Ren · 2012 · Biochemical and Biophysical Research Communications
Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance
Van T. Hoang, A. Zepeda-Moreno, A. D. Ho · 2012 · Biotechnology Journal
How One Thing Led to Another
Irving L. Weissman · 2016 · Annual Review of Immunology
Targeting Leukemia Stem Cells in the Bone Marrow Niche
Sarah Kathleen Tasian, Martin Bornhäuser, Sergio Rutella · 2018 · Biomedicines
CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma
YE Xiaojing, Xiaojun Wang, Rui Lü, Jing Zhang, Xinming Chen, Gang Zhou · 2018 · Oncology Letters
Molecular functions of SIRPα and its role in cancer (Review)
Shinichiro Takahashi · 2018 · Biomedical Reports
Targeting tumor cells with antibodies enhances anti-tumor immunity
Zhichen Sun, Yang‐Xin Fu, Hua Peng · 2018 · Biophysics Reports
Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy
Seung‐Yoon Park, In‐San Kim · 2019 · Cancer Letters
Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade
Katie L. Anderson, Kristin M. Snyder, Daisuke Ito, Debra C. Lins, Lauren J. Mills, Kipp Weiskopf, Nan Guo Ring, Aaron M. Ring, Yoji Shimizu, Matthew F. Mescher et al. · 2019 · Melanoma Research
Novel fully human anti‐CD47 antibodies stimulate phagocytosis and promote elimination of AML cells
Chaoyu Wang, Chengtao Sun, Mengzhen Li, Bing Xia, Yi Wang, Li Zhang, Yanyan Zhang, Juan Wang, Feifei Sun, Suying Lü et al. · 2020 · Journal of Cellular Physiology
Targeting Cancer Stem Cells with Defined Compounds and Drugs
Cord Naujokata, Stefan Laufer · 2013 · Journal of cancer research updates
The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
Zahra Beizavi, Seyed Mohammad Gheibi Hayat, Hadis Moghadasian, Hossein Zare, Babak Shirazi Yeganeh, Hassan Askari, Sina Vakili, Amir Tajbakhsh, Amir Savardashtaki · 2021 · Molecular Biology Reports
Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties
Héléna Boutzen, Alex Murison, Alexa Oriecuia, Suraj Bansal, Christopher Arlidge, Jean C. Y. Wang, Mathieu Lupien, Kerstin B. Kaufmann, John Edgar Dick · 2024 · Leukemia
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis
Naval Guastad Daver, Jayastu Senapati, Hagop M. Kantarjian, Bofei Wang, Patrick Kevin Reville, Sanam Loghavi, Musa E. Yilmaz, Courtney Denton Dinardo, Tapan Mahendra Kadia, Mhd Yousuf Yassouf et al. · 2025 · Clinical Cancer Research
Protein S and Gas6 induce efferocytosis of HIV-1-infected cells
Bernadette Anne Chua, Jamie Ann Ngo, Kathy Situ, Christina M. Ramirez, Haruko Nakano, Kouki Morizono · 2018 · Virology
Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
Norimichi Hattori, Tsuyoshi Nakamaki · 2019 · International Journal of Molecular Sciences
MicroRNA‐200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47
Yunteng Zhao, Xiaoxiao Yu, Haocheng Tang, Ri Han, Xianwen Wang, Jianqi Wang, Ke Wang, Gang Li · 2020 · BioMed Research International